Add to Favorites Newsroom RSS Share
Cambridge, MA USA

Our News on Newswise

Law and Disorder—APPswe Patent Suits Raise Ruckus Again

Is this the modus operandi for a self-described "leading not-for-profit research and development institution" that is suing 10 AD research entities, from pharma and biotech companies to not-for-profit institutions, over use of mice, cells, and other...
29-Jun-2010 8:00 PM EDT Add to Favorites

Towards Clinical Trials in Very Early Alzheimer Disease - Before Symptoms Appear

On the 9 June 2010, 119 participants from industry, academia, and related stakeholder communities in the U.S. and Europe joined Alzforum for a Webinar with Alzheimer's Disease Cooperative Study (ADCS) director Paul Aisen, who explained what kinds of...
14-Jun-2010 2:05 PM EDT Add to Favorites

Deep-Brain Stimulation: Calms PD Shakes—What About the Mind?

A surgical treatment that stimulates distressed neural networks through electrodes threaded directly into a person's brain has quietly made a difference in the lives of tens of thousands of people with Parkinson disease, essential tremor, and...
27-May-2010 9:00 AM EDT Add to Favorites

Genetic Mutation Associated with Famous Alzheimer Patient May Have Been Identified

Writing the latest pages of an anthropological mystery, scientists propose in this month’s Archives of Neurology that it is highly possible that Auguste Deter, the first identified Alzheimer disease patient, carried the N141I presenilin-2...
25-May-2010 12:25 PM EDT Add to Favorites

Biomarkers Weigh In at Mild Cognitive Impairment Meeting

Forget sun, sand, and surf—it was biomarker pools and a sea change in neurocognitive testing that rejuvenated attendees at the 8th Annual Symposium on Early Alzheimer's, held 12-13 March 2010, in Miami Beach, Florida. Our intrepid reporter Pat...
20-Apr-2010 2:45 PM EDT Add to Favorites

Has the Clock Struck 12 for Dimebon?

The Alzheimer Research Forum, an authoritative news source for neurodegenerative disease research, has reported extensively on the story of Dimebon, which was just reported to have failed in a clinical trial.
8-Mar-2010 8:00 AM EST Add to Favorites

Alzforum's 5-Part Series on Alzheimer’s Prevention Initiative

The field is abuzz with the word “prevention,” but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot,...
5-Mar-2010 8:50 AM EST Add to Favorites

Vision of Shared Prevention Trials Lures Pharma to Table

The field of Alzheimer disease research is abuzz with the word “prevention,” but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led...
26-Feb-2010 11:50 AM EST Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!